Mindstate Design Labs

Experience is an engineerable output of biology.

[Dillan DiNardo @DillanDiNardo]

Part 1 of 3 dropping in the next few months... before the release that puts it all together.

This paper applies LLMs to some of our pre-LLM hypothesis generation work.

Huge thank you to @danilobzdok, @RCarhartHarris, @FredBarrettPhD, and the whole @MindstateDesign team.

[Mindstate Design Labs @MindstateDesign]

@RCarhartHarris @danilobzdok Well done, team!

[Robin Carhart-Harris @RCarhartHarris]

Grateful to have been included in this novel and interesting work. @danilobzdok https://t.co/729et7uJuU

[Mindstate Design Labs @MindstateDesign]

Mindstate Design Labs welcomes Graeme Bell to our Board of Directors! Graeme has served as CFO of Merck USA and CFO of Valo Health, and is currently CFO of Owkin. His track record scaling frontier biotech and AI platforms comes at the perfect moment as we push forward the future of programmable neurobiology.
https://t.co/uHMb7phuTR

[Day One Ventures @DayOneVC]

Only 3 mental states are available by prescription today

@MindstateDesign is opening up the other 98%

Congrats to @DillanDiNardo + team on this huge milestone

[Dillan DiNardo @DillanDiNardo]

1/ It feels surreal to announce completion of the first human trial in the development of our neurotech platform for designing mental states, from the molecular level.

Human experience is now programmable.

A🧵on the sequel to psychedelics & the first new "emotion in a bottle."

[One Mind @OneMindOrg]

🚀 MEET THE #2025OMA COHORT:⁠ @MindstateDesign

Mindstate Design Labs is a techbio platform & psychiatric therapeutics company that is repurposing the mechanisms of #psychedelics to deliver transient psychoactive states & targeted reintegrations of neural connectivity.

Mindstate Design Labs, a @ycombinator company that raised a seed round led by @Initialized Capital with participation from other venture funds & angels including founders of @OpenAI & @neuralink, was founded by biotech venture investor @DillanDiNardo & evolutionary biologist & computer scientist Dr. Thomas Ray, creator of the first self-evolving artificial life program & collaborator of “godfather of psychedelics” #AlexanderShulgin.

Mindstate Design Labs' mission is to transform the mental health crisis by enabling the safe, consistent delivery of novel psychoactive effects.

Learn more at https://t.co/DbHQv4z3J3

[Big Think @bigthink]

This company is using AI to engineer new psychedelics. What they create could lead to novel therapies and better our understanding of consciousness. @DillanDiNardo @MindstateDesign

[Mindstate Design Labs @MindstateDesign]

@DamianBullish 🙏 Several announcements coming soon!

[Mindstate Design Labs @MindstateDesign]

🙏🙏🙏 Inspiring words from the legendary @JasonSilva!

[Jason Silva @JasonSilva]

A new kind of authorship over our subjectivity with @MindstateDesign - taking control of our innerverse! #mind #consciousness #mentalhealth #healing #mindstatedesign

[Dillan DiNardo @DillanDiNardo]

Fantastic piece on the future of psychedelics in @TIME from @Jamie_Ducharme.

We don't have to accept the unpredictability of popular legacy psychedelics; we should work toward precision-designing modified conscious states.

https://t.co/AVq74Xjps7

[Mindstate Design Labs @MindstateDesign]

@ecommartinez Es hora de ir más allá de los "psicodélicos" y comenzar el diseño de precisión del estado de ánimo, la cognición y la percepción!

[Dillan DiNardo @DillanDiNardo]

1/ We're thrilled to announce we've received both FDA & EMA approval to begin human trials in the development of our neurotech platform for designing altered states. It’s time to move beyond “psychedelics” and begin the precision design of mood, cognition, and perception. (1/9)

[Dillan DiNardo @DillanDiNardo]

The Shulgin Farm is launching a funding campaign to preserve and open the property as a cultural center. The Farm is truly a physical, intellectual, and spiritual landmark of major societal significance, and I'm glad to see it preserved.
https://t.co/AaMscAkPFC

[Mindstate Design Labs @MindstateDesign]

"Our mission at Mindstate is to...use those first-generation [psychedelic] compounds as tools to probe the architecture of the human mind." - @DillanDiNardo, CEO of @MindstateDesign, speaking with @garrytan in late 2023. #psychedelics #consciousness
https://t.co/IyHyr4mDMe

[Mindstate Design Labs @MindstateDesign]

@mrmichaelpower @DillanDiNardo @samalanascience @DrMorisano Maybe we should specify "silken tofu": It takes a professional to know how to utilize it properly.

[Initialized Capital @Initialized]

Mindstate Design Labs has applied to the FDA for an IND to begin clinical trials for their lead drug candidate targeting the psychedelic compound 5-MeO-MiPT, also known as moxy. The company analyzed over 70,000 reports from people who used psychedelics to select this compound.

Thank you Max Bayer for sharing their story in @FierceBiotech ⬇️

https://t.co/mC3lcgm1hE

[Dillan DiNardo @DillanDiNardo]

1/ We've filed the IND for our lead MSD-001, a formulation of 5-MeO-MiPT. 5-MeO-MiPT’s unique pharmacology & phenomenology make it the ideal “primer” for enabling the intentional design of conscious states with fixed-dose combination psychedelics.
https://t.co/DQpwLTYJlv

[Initialized Capital @Initialized]

@DillanDiNardo, @MindstateDesign’s CEO, believes mental health will remain a top concern in 2024, with the intersection of AI and neuroscience potentially leading to groundbreaking advancements in understanding and addressing mental health challenges.

Read more 2024 predictions from our healthtech leaders ⬇️
https://t.co/yEgNGZTJU5

[Eric Topol @EricTopol]

"Neuroscientists today are literally 'drowning in information but starving for knowledge'’.’
A *brilliant* review for how large language model #AI is changing that, as biology becomes an engineering discipline
https://t.co/2QvkurHp2w @NeuroCellPress
@danilobzdok @sivareddyg